Company · Ownership research

SHORE BANCSHARES INC SHBI

CIK 0001035092

Form 4 transactions dated Nov 1, 2023 to Nov 12, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 98 rows; the complete set is available through the API.

Insider filings on file run through Oct 29, 2026.

Insider purchases & sales

Purchased: $1.02M
Sold: $33.84K

Nov 1, 2023 – Oct 29, 2026
Available records · partial months are marked ·

Insiders in this window

202510 of 12 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Nov 26, 2025	Willey Dawn M. Director	Purchase	$17.67K 1,000 shares bought	9.09% added Indirect holding	▾
Nov 18, 2025	Kaslow Aaron Michael EVP, Chief Legal Officer	Purchase	$101.14K 6,500 shares bought	New holding Direct holding	▾
Nov 7, 2025	LAMON JOHN Director	Purchase	$3.18K 200 shares bought	0.32% added Direct holding	▾
Aug 13, 2025	WAYSON KONRAD Director	Purchase	$16.02K 1,000 shares bought	1.67% added Trust holding	▾
Aug 1, 2025	Adams Michael Brian Director	Purchase	$150.00K 10,000 shares bought	28.64% added Direct holding	▾
May 30, 2025	LAMON JOHN Director	Purchase	$3.64K 250 shares bought	0.40% added Direct holding	▾
May 30, 2025	Willey Dawn M. Director	Purchase	$14.58K 1,000 shares bought	6.03% added Direct holding	▾
May 30, 2025	Streete Esther A. Director	Purchase	$437.49 30 shares bought	4.78% added Direct holding	▾
May 2, 2025	Adams Michael Brian Director	Purchase	$7.92K 560 shares bought	6.09% added Indirect holding	▾
May 2, 2025	WAYSON KONRAD Director	Purchase	$71.25K 5,000 shares bought	9.20% added Trust holding	▾

Showing 12 / 12 record groups in 2025. The complete set is available through the API.

SHORE BANCSHARES INC · SHBI

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 12 of 12 purchase / sale groups and 30 of 98 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"SHBI","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.